Top Markets
#1 Islamic Coin Islamic Coin +152.22%
#2 Bitway Bitway +67.08%
#3 Starpower Starpower +34.74%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +28.76%
#5 aelf aelf +26.48%
#6 Pons Pons +16.47%
#7 Decred Decred +14.39%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +14.08%
#9 Ribbita by Virtuals Ribbita by Virtuals +13.52%
#10 DAPPOS DAPPOS +10.73%
Coin of the day
Islamic Coin Islamic Coin
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Tvardi Therapeutics, Inc. Tvardi Therapeutics, Inc.

Tvardi Therapeutics, Inc.

TVRD
Rang in aandelen #30263
Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages... Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting signal transducer and activator of transcription 3 (STAT3) to treat inflammatory and proliferative diseases with significant unmet need in the United States. The company's lead product candidates include TTI-101, which is in Phase 1b/2 clinical development stage for fibrosis-driven diseases with an initial focus on idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC); and TTI-109, an oral, small molecule STAT3 inhibitor which is in Phase-1 clinical trial stage. Tvardi Therapeutics, Inc. was founded in 2017 and is based in Sugar Land, Texas.
Aandeelprijs
$1.88
Laatst gesynchroniseerd: 2026-08-18
Marktkapitalisatie
$17.59M
Verandering (1 dag)
0.81%
Verandering (1 jaar)
-92.40%
Land
US
Handel Tvardi Therapeutics, Inc. (TVRD)

Categorie

Healthcare
P/S-ratio voor Tvardi Therapeutics, Inc. (TVRD)
P/S-ratio op 2026 TTM: 0
Volgens de meest recente financiële rapporten en aandelenkoers van Tvardi Therapeutics, Inc. is de huidige P/S-ratio (TTM) 0. Eind 2026 had het bedrijf een P/S-ratio van 0.
P/S-ratiohistoriek voor Tvardi Therapeutics, Inc. van 2026 tot 2026
P/S-ratio aan het einde van elk jaar
Jaar P/S-ratio Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
P/S-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/S-ratio Verschil in P/S-ratio Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR